Delivery Order SPE2DB20D7059-SPE2DB25FQAD7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,147.43 delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML with dextrose solution, with a firm fixed price and an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextrose solution, a commonly used antibiotic pharmaceutical product. The contract was competitively awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, and reflects a firm fixed-price arrangement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solution, valued at $1,228.56, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a $2,457.12 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution, with an ultimate completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract, indicating it was issued under a larger indefinite delivery vehicle. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,754.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-compete, non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.12 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This competitively awarded contract utilizes firm fixed-price terms with an ultimate completion date of September 9, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose, a pharmaceutical product used primarily as an antibiotic in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a $3,163.02 delivery order (Contract No. 4568590593) to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML-Dextroses, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and is scheduled for completion by June 20, 2025. Performance will be fulfilled from AmerisourceBergen's facility in...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQAD7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,047.50 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextrose solution. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on February 20, 2025, with an ultimate completion date of February 21, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills essential pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of Cefazolin, a broad-spectrum antibiotic commonly used in surgical prophylaxis and acute infections within military medical settings, exemplifies the company's role in supplying routine medical commodities that support military personnel and veteran healthcare operations. This transaction reflects the ongoing demand for injectable antibiotics within the federal supply chain managed through DLA's medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/20/25 |